Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apartment Investment and Management | AIV | Sep 27, 2024 | 9.13 | -1.40 |
Apellis Pharmaceuticals | APLS | Sep 27, 2024 | 29.47 | -1.27 |
APi Group | APG | Sep 27, 2024 | 33.64 | -0.91 |
Apogee Enterprises | APOG | Sep 27, 2024 | 69.81 | +0.20 |
Apogee Therapeutics | APGE | Sep 27, 2024 | 57.99 | -0.09 |
Apollo Commercial Real Estate Finance | ARI | Sep 27, 2024 | 9.43 | +0.21 |
Apollo Global Management | APO | Sep 27, 2024 | 125.81 | +0.25 |
Apollomics A | APLM | Sep 27, 2024 | 0.13 | -1.50 |
AppFolio A | APPF | Sep 27, 2024 | 234.54 | -0.75 |
Appian A | APPN | Sep 27, 2024 | 34.94 | -0.09 |
Apple | AAPL | Sep 27, 2024 | 227.79 | +0.12 |
Apple Hospitality REIT | APLE | Sep 27, 2024 | 15.14 | +0.33 |
Applied Digital | APLD | Sep 27, 2024 | 8.19 | -0.73 |
Applied DNA Sciences | APDN | Sep 27, 2024 | 0.93 | -8.08 |
Applied Industrial Technologies | AIT | Sep 27, 2024 | 223.06 | +0.51 |
Applied Materials | AMAT | Sep 27, 2024 | 204.92 | -2.24 |
Applied Optoelectronics | AAOI | Sep 27, 2024 | 13.73 | -7.26 |
Applied Therapeutics | APLT | Sep 27, 2024 | 8.27 | -1.66 |
Applovin A | APP | Sep 27, 2024 | 127.75 | -0.30 |
AppTech Payments | APCX | Sep 27, 2024 | 0.60 | -1.80 |
Aprea Therapeutics | APRE | Sep 27, 2024 | 2.75 | -5.82 |
AptarGroup | ATR | Sep 27, 2024 | 159.89 | +0.95 |
Aptevo Therapeutics | APVO | Sep 27, 2024 | 0.18 | -0.39 |
Aptiv | APTV | Sep 27, 2024 | 74.24 | +2.67 |
Aptorum Group A | APM | Sep 27, 2024 | 1.85 | -1.33 |
Aptose Biosciences | APTO | Sep 27, 2024 | 0.41 | +1.27 |
APx Acquisition I A | APXI | Sep 27, 2024 | 11.65 | +0.09 |
APx Acquisition I Unit | APXIU | Sep 27, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Sep 27, 2024 | 1.20 | +2.13 |
Aqua Metals | AQMS | Sep 27, 2024 | 0.20 | +4.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.